Form 4: Alumis Inc. CFO John R. Schroer Reports Stock Option Grant
SEC Form 4 Filing
Alumis Inc.'s Chief Financial Officer, John R. Schroer, reported the acquisition of stock options in the company.
Summary
- On February 18, 2025, John R. Schroer, the Chief Financial Officer of Alumis Inc., was granted stock options to purchase 140,000 shares of Alumis Inc. common stock.
- The exercise price of the options is $5.06 per share.
- 25% of the shares underlying the option vest on February 18, 2026, and the remaining shares vest in equal monthly installments over the following 36 months, contingent upon continuous service to Alumis Inc.
Sentiment
Score: 6
Explanation: The document is a routine disclosure of a stock option grant, which is generally neutral. It indicates confidence in the company's future, but doesn't provide specific financial details.
Positives
- The grant of stock options to the CFO aligns his interests with those of the shareholders, incentivizing him to improve the company's performance.
- The vesting schedule encourages long-term commitment from the CFO.
Future Outlook
The vesting schedule suggests a commitment to the company's future performance over the next several years.
Industry Context
Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders and incentivizing long-term value creation.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in the biotech industry.
- Companies like Amgen, Gilead, and Biogen also utilize stock options to incentivize their executives.
- The vesting schedule and exercise price are typical for similar grants in companies of Alumis Inc.'s size and stage of development.
Stakeholder Impact
- Shareholders may view the stock option grant as a positive sign, aligning management's interests with their own.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date of the stock option grant. |
| 02/18/2026 | Date when 25% of the stock options vest. |
| 02/17/2035 | Expiration date of the stock options. |
| 02/20/2025 | Date of signature on the Form 4 filing. |
Keywords
stock options, Form 4, insider trading, ALMS, Alumis Inc., CFO, John R. Schroer, equity compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.